wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38002190-D174021F-C9E9-48DB-AEA4-D9B7E86E93D2
Q38002190-D174021F-C9E9-48DB-AEA4-D9B7E86E93D2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38002190-D174021F-C9E9-48DB-AEA4-D9B7E86E93D2
Advantages of blood pool contrast agents in MR angiography: a pictorial review.
P2860
Q38002190-D174021F-C9E9-48DB-AEA4-D9B7E86E93D2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38002190-D174021F-C9E9-48DB-AEA4-D9B7E86E93D2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
761f105f9b06300137cb8ccfd283aaf980c8c294
P2860
A summary of safety of gadofosveset (MS-325) at 0.03 mmol/kg body weight dose: Phase II and Phase III clinical trials data.